Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY.
The item "Diluted-EPS" stands at 47.58 Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Sumitomo Dainippon Pharma Co Ltd's first quarter result of 28.21 JPY for the item "Diluted EPS" represents an increase of 364.02 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 28.21 JPY for the item "Diluted EPS" represents a decrease of -29.69 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of 47.58 JPY for the item "Diluted EPS" represents a decrease of -20.02 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 702.43 Japanese Yens compared to the value the year prior.
The 1 year change is 702.43 Japanese Yens.
The 3 year change is -160.63 Japanese Yens.
The 5 year change is -84.08 Japanese Yens.
The 10 year change is 8.23 Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Diluted EPS | 905,699,262,464.00 |
![]() | Johnson & Johnson - Diluted EPS | 486,508,953,600.00 |
![]() | AbbVie Inc - Diluted EPS | 399,570,305,024.00 |
![]() | Roche Holding AG - Diluted EPS | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Diluted EPS | 280,205,508,085.11 |